INSIGHTS ON CLINICAL TRIAL DESIGN

CLINICAL TRIAL DESIGN SOLUTIONS

  • Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.

  • Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:

    • Narrow I/E criteria that don’t translate into real-world patients
    • Sites with limited behavioral health infrastructure
    • Lack of patient trust and trial awareness in psychiatric populations
    • Professional patients
    • Rating scales aren’t used in clinical practices

    But what if recruitment didn’t have to start with a gamble?

  • Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.

  • With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.

  • Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.